361 related articles for article (PubMed ID: 33538960)
1. Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients.
Deb S; Arrighi S
Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):185-203. PubMed ID: 33538960
[TBL] [Abstract][Full Text] [Related]
2. Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions.
Lim SYM; Al Bishtawi B; Lim W
Eur J Drug Metab Pharmacokinet; 2023 May; 48(3):221-240. PubMed ID: 37093458
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
5. The Effects of CKD on Cytochrome P450-Mediated Drug Metabolism.
Ladda MA; Goralski KB
Adv Chronic Kidney Dis; 2016 Mar; 23(2):67-75. PubMed ID: 26979145
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
7. Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms.
El-Ghiaty MA; Shoieb SM; El-Kadi AOS
Med Hypotheses; 2020 Nov; 144():110033. PubMed ID: 32758877
[TBL] [Abstract][Full Text] [Related]
8. Regulation of drug metabolism and disposition during inflammation and infection.
Renton KW
Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):629-40. PubMed ID: 16863429
[TBL] [Abstract][Full Text] [Related]
9. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
[TBL] [Abstract][Full Text] [Related]
10. Recovery of hepatic function determined by cytochrome P450-dependent drug metabolism lags after compensatory hepatic volume changes after portal vein ligation in rats.
Takemura S; Minamiyama Y; Hirohashi K; Kubo S; Funae Y; Kinoshita H
J Surg Res; 2006 Aug; 134(2):285-91. PubMed ID: 16564546
[TBL] [Abstract][Full Text] [Related]
11. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
[TBL] [Abstract][Full Text] [Related]
13. The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits.
Saitoh T; Kokue E; Shimoda M
J Vet Pharmacol Ther; 1999 Apr; 22(2):87-95. PubMed ID: 10372593
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cytochrome P450 enzymes in inflammation and cancer: a review.
Stipp MC; Acco A
Cancer Chemother Pharmacol; 2021 Mar; 87(3):295-309. PubMed ID: 33112969
[TBL] [Abstract][Full Text] [Related]
15. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.
Prandota J
Am J Ther; 2005; 12(3):254-61. PubMed ID: 15891270
[TBL] [Abstract][Full Text] [Related]
16. The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy.
Wang G; Xiao B; Deng J; Gong L; Li Y; Li J; Zhong Y
Front Pharmacol; 2022; 13():791922. PubMed ID: 35185562
[TBL] [Abstract][Full Text] [Related]
17. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure.
Carcillo JA; Doughty L; Kofos D; Frye RF; Kaplan SS; Sasser H; Burckart GJ
Intensive Care Med; 2003 Jun; 29(6):980-984. PubMed ID: 12698250
[TBL] [Abstract][Full Text] [Related]
19. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
Knights KM; Rowland A; Miners JO
Br J Clin Pharmacol; 2013 Oct; 76(4):587-602. PubMed ID: 23362865
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 Enzymes and Drug Metabolism in Humans.
Zhao M; Ma J; Li M; Zhang Y; Jiang B; Zhao X; Huai C; Shen L; Zhang N; He L; Qin S
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
